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HIGHLIGHTS
• Proteome-wide analysis of Exonuclease-1 (EXO1) interacting proteins revealed novel partners involved in RNA processing or that are the causative agents of rare X-linked disorders.
• We provide evidence for a role of PDCD11 in the DNA Damage Response.
• We conducted a comprehensive identification of EXO1 phosphorylation sites.
INTRODUCTION
The human genome is continuously challenged by different types of insults, with thousands of lesions occurring to DNA every day in each cell [1] . DNA damage arise either as byproduct of normal cellular metabolism and DNA replication or is induced by external factors [2] . DNA double-strand breaks (DSBs) are the most dangerous lesions generated by ionizing radiation (IR), certain chemotherapeutic drugs, collapse of stalled DNA replication forks, endogenous metabolic processes, or arising during meiotic recombination or immunoglobulin diversity generation [3] [4] [5] [6] . DSBs are estimated to occur at a rate of ten per cell per day in primary human or mouse fibroblasts [7] . Inappropriate repair of DSBs interferes with DNA replication and transcription and may cause gross chromosomal aberrations [8] , resulting in developmental defects, neurodegeneration, aging, immunodeficiency, radiosensitivity and sterility [9] or facilitating the development of cancer through the activation of oncogenes or the inactivation of tumor suppressor genes [10] . DNA damage response (DDR) pathways have evolved as surveillance and protection mechanism to counteract the adverse consequences of DNA lesions and to prevent their transmission to daughter cells [11] .
Exonuclease-1 was originally identified in S. pombe (Exo1) [12] and subsequently in humans (EXO1) [13] as an enzyme belonging to the Rad2 family of DNA repair nucleases and able to remove mononucleotides from the 5' end of the DNA duplex [14] . EXO1 is implicated in several DNA repair pathways including mismatch repair, post-replication repair, meiotic and mitotic recombination and double-strand break repair [15] [16] [17] [18] [19] . S. cerevisiae Exo1 acts redundantly with Rad27 in processing Okazaki fragments during DNA replication [20] and is recruited to stalled replication forks where it counteracts fork reversal [21] .
We have previously shown that human and yeast EXO1 are tightly regulated by interaction with CtIP/RBBP8 and 14-3-3 proteins at DSBs and stalled forks, respectively [8, 22, 23] . Additionally, human EXO1 is controlled by post-translational modifications (PTMs), with ATR-dependent phosphorylation targeting it to ubiquitinmediated degradation upon replication fork stalling [24, 25] , and ATM-dependent phosphorylation restraining its activity during homologous recombination [26] .
Analogously, Mec1-dependent phosphorylation was shown to inhibit yeast Exo1 activity at uncapped telomeres [27] . Evidence was provided for a role of Cyclindependent kinase (CDK) -dependent phosphorylation of human EXO1 in the pathway choice of DSB repair [28] . Adding a further layer of complexity to the regulation of EXO1, we have recently shown that its resection activity is controlled by SUMOylation [29] .
Overall, the experimental evidence so far available qualifies EXO1 as a multifaceted protein participating to pathways deputed to the control of genome stability.
Considering this, the identification of factors cooperating with EXO1 at sites of damage or controlling its localization and stability in the cell is expected to shed further light on the function of this important nuclease. In this study, we report the identification of novel EXO1 interaction partners. Specifically, we combined Strep-Tactin technology and Orbitrap mass spectrometry (LC-MS-MS) to identify a large set of interacting proteins, among which are ubiquitin E3-ligases, proteins involved in RNA processing and causative agents of rare X-linked disorders. Additionally, the high yield of EXO1 protein allowed identification of novel sites of post-translational modification.
The PCR product was inserted between the SacII and BamHI restriction sites of pEXPR-IBA3 to generate a translational fusion between EXO1b and a tandem StrepTag, separated by a two-amino acid spacer. The construct was verified by sequencing.
Cell culture
HEK-293T human embryonic kidney cells and U2-OS human osteosarcoma cells (American Type Culture collection, Manassas, VA, USA) were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 10% fetal calf serum (Gibco) and penicillin/streptomycin (100 U/ml; Gibco).
For transfection experiments, cells were seeded in 10 cm dishes and allowed to adhere overnight. Cells were transiently transfected with constructs of interest or the empty vector using 1 µg of the DNA and 4 µl of the transfecting reagent Metafectene (Biontex, Germany) according to the manufacturer instructions. Cells were collected and lysed 48 h after transfection using protocols for isolation of total proteins [8] .
When required, cells were treated with either HU (2 mM, 16h), CPT (1 µM, 4h) or bleomycin (10 µg/ml, 1h). Alternatively, cells were exposed to 10 Gy ionizing radiation using a Faxitron Cabinet X-ray system, model 43855D (Faxitron X-ray Corp., Wheeling, IL, USA), and harvested 1h post-exposure.
RNA interference
Two oligonucleotides for each target were purchased at Qiagen (Switzerland) and transfected at 40 nM concentration using Truefect-Lipo (United BioSystems Inc. USA) according to the manufacturer instructions. Experiments were typically performed for 48-72 h.
Cell viability
Cells were seeded and grown for 24h in full medium. For RNAi experiments, cells were transfected with control or specific siRNA oligonucleotides and, after 24h, re-seeded in 96-well plates at density 1-1. Protein pellets were washed in 1 ml of 10% ice-cold TCA, vortexed and centrifuged.
Finally, pellets were washed with 1 ml of ice-cold HPLC-grade acetone, centrifuged and air-dried. Protein pellets were stored at -80 o C until the time of analysis.
Silver staining
All reagents were prepared in MilliQ-ddH 2 O and solvents were of HPLC quality.
Polyacrylamide gels were fixed in 50% methanol, 5% acetic acid in ddH 2 The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium [33] via the PRIDE partner repository, with dataset identifier PXD002780.
Western blot and immunoprecipitation
Proteins were extracted using ice-cold lysis buffer (50 mM Tris-HCl pH 7.5, 120 mM NaCl, 20 mM NaF, 1 mM EDTA, 6 mM EGTA, 15 mM Na-pyrophosphate, 0.5 mM Na-orthovanadate, 1 mM benzamidine, 0.1 mM phenylmethylsulfonyl fluoride and 1%
Nonidet P-40). Protein concentration was determined using the Bio-Rad Protein Assay
Reagent (Bio-Rad). Proteins were separated on SDS-polyacrylamide gels, transferred to polyvinylidene difluoride (PVDF) (GE-Healthcare) and probed with appropriate antibodies. Immunoblot analysis was performed using BioRad Clarity™ Western Substrate (#170-5060) and proteins were visualized with the FUSION SOLOÒ chemiluminescence imaging system (Vilber) [25] . Immunoprecipitation was performed as described previously [24] . To ensure that the observed interactions were not DNAmediated, ethidium bromide was included in all samples during immunoprecipitation.
Immunofluorescence microscopy and image analysis
U2-OS cells grown on cover slips were fixed in 4% formaldehyde (w/v) in PBS for 15 min at room temperature (RT). Cover slips were incubated overnight at 4 °C with primary antibodies followed by Alexa-conjugated secondary antibodies for 1h at RT.
The cover slips were mounted with Vectashield® (Vector Laboratories) containing DAPI. Images were acquired using a Leica fluorescence microscope DM6-B. Nuclei were detected based on the DAPI signal and, for each nucleus, the intensity of DAPI (blue) and g-H2AX (red) signals were extracted using the open-source software, Cell
Profiler [34] . Data were plotted using GraphPad Prism 8.0.2.
Gene network analysis
To assign links between EXO1 and cellular processes through its interacting proteins, 
RESULTS

Identification of EXO1 interacting proteins
To the end of identifying EXO1 interacting proteins, we created a fusion construct encoding EXO1 and a tandem Strep-tag (EXO1-2x-Strep, EXO1-Strep hereafter).
EXO1-Strep was expressed to an extremely low level (Fig. 1A, lane 2 
Validation and characterization of selected EXO1 interacting proteins
To assess the validity of the mass spectrometry data using an independent method, we conducted immunoprecipitation studies on extracts of HEK-293T cells ectopically expressing GFP-EXO1 ( Fig. 2A) . Immunoblot analysis confirmed interaction between GFP-EXO1 and PHF6 (Fig. 2B) , GFP-EXO1 and RNF138 (Fig. S1 ), as well as established partners such as MSH2, MSH6 and 14-3-3 proteins that were taken as positive controls (Fig. 2B) .
To assess the impact of novel EXO1-interacting proteins on the DNA damage response, we proceeded by knocking down the expression of a selected set of proteins in U2-OS cells. Under these conditions, we quantified g-H2AX foci formation in response to treatment with the topoisomerase-1 inhibitor camptothecin, a chemotherapeutic agent known to induce DSBs exclusively during DNA replication through the trapping of DNA topoisomerase 1 cleavage complexes [38] . Immunofluorescence analysis showed a reduction of the DDR marker g-H2AX upon depletion of all selected proteins ( Fig. 3 and Fig. S2 ). Down-regulation of PDCD11 expression appeared particularly effective in decreasing DDR. Since the RRP5-homologue and NFkB-interacting protein PDCD11/ALG-4 has roles in apoptosis [39] , in the generation of mature 18S rRNA
[40] and its absence is frequently observed in cutaneous T-cell lymphoma [41] , we decided to further characterize this candidate protein.
We initially assessed the efficiency of the two siRNA oligonucleotides used to deplete PDCD11 expression. The data showed that both siRNAs were effective in diminishing PDCD11 protein level upon 48h transfection of U2-OS cells (Fig. S3A) . Cell cycle analysis showed that downregulation of PDCD11 caused a slight increase of the G1 cell population and a parallel decrease of S and G2-M cells ( Fig. S3B and S3C ). Cell survival assays upon exposure of cells to camptothecin or the IR-mimetic bleomycin revealed that PDCD11 depletion conferred higher resistance to the DNA damaging agents as compared to siRNA control depleted cells (Fig. 4) . Analysis of the DDR in distinct cell cycle populations revealed that both in G1 and G2-M cells there was a reduced response to the DNA damaging agent bleomycin ( Fig. 5A and 5B). Western blot analysis of the DDR markers CHK1 and KAP1/TRIM28 revealed a decrease of phosphorylation for both proteins in the PDCD11 depleted cells treated with bleomycin (Fig. 5C ).
Taken together, these data indicate that the EXO1 interacting protein PDCD11
participates in the DNA damage response.
EXO1 sites of phosphorylation
Isolation of Strep-EXO1 from HEK293T cells yielded an amount of protein sufficient to cover 86% of EXO1 sequence by Orbitrap mass spectrometry. Hence, posttranslational modifications such as phosphorylation could be reliably scored. The data showed that EXO1 contained 26 sites of phosphorylation in all conditions examined ( Table 2 ). Analysis of peptide features revealed that the majority of the sites that we identified fell into the two largest families of phosphorylation sites described in the literature, namely targets of proline-directed kinases or of acidophylic kinases, accounting in total for about 77% of all detected phosphorylation sites [42] . To the proline-directed kinases class of sites belong residues 475, 598, 621, 623, 639, 814 and 824, whereas to acidophylic kinases target sites belong amino acids 422, 426, 700, 702, 744, 745 and 746 (Table 2) . Among the phosphorylated residues that we have previously described in EXO1 [25] , this study confirmed the presence of S454 and S714
as DNA damage-dependent sites (Fig. 6) . Assessment of peptide intensity upon HU treatment, normalized to the untreated condition, showed an increase of phosphorylation at S454, at the novel target double-site T621/S623 and particularly at the established S714 [25, 26] (Fig. 6 ). Less prominent increase of phosphorylation under these conditions was observed at S422 and S426 (Fig. 6 ). On the other hand, IR appeared to particularly increase phosphorylation at S385 and, to a lesser extent, S714 (Fig. 6 ), in line with our previous reports [25] .
EXO1 gene network
To categorize pathway and cellular processes in which EXO1-interacting proteins have an annotated function, we performed gene network analysis of EXO1 binding partners using the literature-based ResNet Mammalian 11.0 Database in Pathway Studio 11.0
[35]. The resulting interaction network displayed connection (i.e., direct interaction) of EXO1 with various cellular pathways, such as RNA and DNA processing, DNA damage response and cell cycle control (Fig. 7) . Beside the expected connections with established pathways of DNA resection and remodeling, interaction with RNA processing factors enriches the so far known links of EXO1 with the RNA world, consisting in the ability to phenotypically complement deficiency of Rad27 (the yeast homolog of human FEN1) and displaying RNAse H activity in vitro [20] . Our data suggest that EXO1 may be component of mRNA biogenesis complexes that prevent DNA damage generated by aberrant RNA-DNA structures [43, 44] .
DISCUSSION
Dysfunction of the machinery that signals DNA damage and/or addresses DNA repair is associated with cancer development and resistance to therapy [10, 45] , providing a direct demonstration of the link between genome instability and cancer [46] . DSBs, are among the most dangerous lesions that may occur to DNA and are generated by internal metabolic processes [3] [4] [5] [6] [7] or result from the action of external agents, such as ionizing radiation and mutagenic chemicals [47, 48] . Intense effort is currently being devoted to the identification of proteins and pathways involved in the recognition and repair of various forms of DNA damage to reach a better understanding of the molecular mechanism of action of chemotherapeutics currently deployed in the clinic and, based on the knowledge gained on DDR pathways, to develop more efficient drugs that address the lack of specificity and side-effects of current chemotherapeutics. To allow reaching this second objective, DDR pathway components, their mechanism of action and partner interacting proteins must be identified. In the present work, we focused on the identification of phosphorylation sites and interaction partners of EXO1, an essential component of error-free DNA repair pathways.
To investigate the EXO1 interactome we used a Strep-tagged form of EXO1 and took advantage of affinity-based protein enrichment (Fig. 1) . Technically, this approach presents two advantages: (i) it allows eliminating the robust signal of the antibody heavy and light chains that often hampers detection of low-abundance partners of the protein of interest; and (ii) it facilitates identification of weakly interacting proteins by virtue of the mild conditions used for elution of the bait and its partners. Analysis of EXO1 interacting proteins revealed an unexpected network of interaction with proteins involved in RNA metabolism (Table 1 and Fig. 7 ) possibly suggesting participation of EXO1 in pathways addressing the resolution of RNA-DNA hybrids that threaten genome stability [49, 50] . Other interesting hits were the PHD-finger protein 6 and FMR1, two proteins associated with X-linked disorders, namely the BoerjesonForssman-Lehmann syndrome (BFLS) and the Fragile X syndrome / Fragile X tremorataxia syndrome (FRAX / FXTAS), respectively. These disorders are characterized by moderate to severe mental retardation and growth defects among other clinical signatures, reminiscent of conditions observed in patients carrying mutations of DNA repair genes [51] . Published evidence indicates that PHF6 deficiency results in DNA damage, which is particularly evident at the ribosomal DNA (rDNA) locus [52] , and that FMR1 participates in the DDR thanks to its ability to bind chromatin and regulate the DNA damage machinery [53] . Regarding the possible role of EXO1 in these two syndromes, both FRAX and FXTAS are characterized by abnormal amplification and expansion of CGG repeats [54, 55] , suggesting that interaction -and possibly controlof PHF6 or FRM1 on EXO1 as component of the DNA mismatch repair machinery might play an important role in the regulation of repeat expansion [56] .
Characterization of a selected subset of EXO1 interacting proteins by knock-down of their expression in cells undergoing DNA damage revealed an important reduction of the DNA damage response (DDR) in all cases examined ( Fig. 3 and S2 ). Among these proteins, the RRP5-homologue and NFkB-interacting protein PDCD11/ALG-4 attracted our attention due to its roles in apoptosis [39] , in the generation of mature 18S
rRNA [40] and, particularly, because of the frequent aberrations (single nucleotide variations, SNV, and copy number variations, CNV) observed in cutaneous T-cell lymphoma, leading to the proposal of PDCD11 as putative driver gene for this type of pathology [41] . We obtained evidence that PDCD11 depletion rendered cells more resistant to camptothecin or bleomycin (Fig. 4) , possibly through a mechanism that results in a decreased response to DNA damage (Fig. 5 ). In line with our findings, yeast RRP5 was reported to physically interact with Rad27, a 5' to 3' exonuclease and 5' flap endonuclease that is required for Okazaki fragment processing [57] , participates in long-patch DNA base-excision repair [58] as well as ribonucleotide excision repair [59] and, like EXO1, is member of the S. pombe RAD2/FEN1 family.
Isolation of EXO1-Strep from HEK293T cells using the StrepTactin system yielded an amount of protein ( Fig. 1 ) sufficient to cover 86% of EXO1 sequence by mass spectrometry. Hence, post-translational modifications such as phosphorylation could be reliably scored (Table 2 ). Among the sites that we have previously described in EXO1 [25], S422, S454 and S714 were the most prominent residues displaying increased phosphorylation in response to replication stress, with S426 and the doublet T621/S623 being novel sites undergoing similar control (Fig. 6) . The newly identified S385 appeared to be the more responsive to ionizing radiation than replication stress (Fig. 6 ). S714 is an S/T-Q type site, targeted by ATR [25] and to a lesser extent ATM [25, 26] , whereas S454 displays the features for recognition by checkpoint kinases (F-X 1 -K/R-X 2 -pS/pT, where F is any hydrophobic amino acid). S385, S422 and S426 are suitable sites for CK2 (pS/pT-X 0-2 -D/E 1-5 ), whereas T621/S623 are typically Prodirected kinase sites (pS/pT-P). Hence, these data indicate that in addition to classic DDR kinases, also CK2 and possibly stress-activated MAPK members participate in the control of EXO1 in response to genotoxic damage. The majority of the remaining sites, phosphorylation of which did not substantially change in response to DNA damage, could be assigned to the AGC and the CMGC subfamilies of protein kinases or to CK1. Among the residues targeted by Pro-directed kinase are cell cycle regulated sites, the phosphorylation of which was shown to depend on CDK2 in S-and G2-phase and to peak in prometaphase-arrested cells when CDK1 activity is maximal [28] .
The identification of novel EXO1 interacting proteins presented here, such as the causative agents of X-linked syndromes, which have been previously linked to DDR, or PDCD11, which represents a novel entry, warrants future studies on the molecular mechanism by which these proteins specifically affect EXO1 function and, in general, participate in cellular responses to genotoxic damage. The additional comprehensive identification of EXO1 phosphorylation sites adds another layer of complexity to the mechanism that control EXO1 localization and function at sites of damage.
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Figure 6 -Identification of phosphorylation sites in Strep-EXO1
Graphic representation of intensity signal for the identified phospho-peptides (see Table 2 ) after normalization to the signal of the same phospho-peptides in the untreated condition. (Fig. 2) are indicated with an asterisk.
TABLES
Entries analyzed in RNA-interference studies are indicated with a double asterisk. 
